Pyxis Oncology, Inc.
Pyxis Oncology, Inc. (PYXS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PYXS · as of Jun 8, 2026
Key Statistics
Explore Pyxis Oncology, Inc. Data
pyxs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 77.8%
The PYXS analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $5.50, representing +222.41% upside from the current price of $1.71.
Competitors & Peers
pyxs competitorsPYXS
AVIR
CRBU
ENTA
FHTX
HUMAStock Performance
Full HistoryAbout Pyxis Oncology, Inc.
Pyxis Oncology, Inc. a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigationa…
what is pyxis oncology, inc. · pyxs stock overview · pyxis oncology, inc. company profile · who is pyxis oncology, inc. ceo · pyxs NASDAQ · pyxis oncology, inc. headquarters · pyxis oncology, inc. business segments
About Stock Overview & Key Data
Pyxis Oncology, Inc. (PYXS) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Oct 8, 2021. As of the latest trading session, PYXS stock price is $1.71, with a market capitalization of $107.4M. The stock has returned +25.56% over the past 12 months and +47.39% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Pyxis Oncology, Inc. stock is Buy, with an average 12-month price target of $5.50. In fiscal year 2025, Pyxis Oncology, Inc. reported revenue of $13.9M and net income of -$79.6M. For detailed data — including Pyxis Oncology, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pyxis Oncology, Inc. (PYXS) stock price is $1.71. The stock is traded on NASDAQ under the ticker symbol PYXS. The 52-week range is $0.97 – $5.55.